[1] R.L. Siegel, K.D. Miller and A. Jemal, Cancer statistics, 2019, CA Cancer J Clin69 (2019), 7-34.
[2] X. Xu, R. Bi, R. Shui, B. Yu, Y. Cheng, X. Tu and W. Yang, Micropapillary pattern in pure mucinous carcinoma of the breast - does it matter or not?, Histopathology74 (2019), 248-255.
[3] E. Marrazzo, F. Frusone, F. Milana, A. Sagona, W. Gatzemeier, E. Barbieri, A. Bottini, G. Canavese, A.O. Rubino, M.G. Eboli, C.M. Rossetti, A. Testori, V. Errico, A. De Luca and C. Tinterri, Mucinous breast cancer: A narrative review of the literature and a retrospective tertiary single-centre analysis, Breast49 (2020), 87-92.
[4] S.Y. Bae, M.Y. Choi, D.H. Cho, J.E. Lee, S.J. Nam and J.H. Yang, Mucinous carcinoma of the breast in comparison with invasive ductal carcinoma: clinicopathologic characteristics and prognosis, J Breast Cancer14 (2011), 308-13.
[5] F. Limaiem and F. Ahmad, Mucinous Breast Carcinoma, in: StatPearls, Treasure Island (FL), 2020.
[6] W.K. Ng, Fine-needle aspiration cytology findings of an uncommon micropapillary variant of pure mucinous carcinoma of the breast: review of patients over an 8-year period, Cancer96 (2002), 280-8.
[7] A.C. Chen, A.C. Paulino, M.R. Schwartz, A.A. Rodriguez, B.L. Bass, J.C. Chang and B.S. Teh, Population-based comparison of prognostic factors in invasive micropapillary and invasive ductal carcinoma of the breast, Br J Cancer111 (2014), 619-22.
[8] K. Collins and A. Ricci, Jr., Micropapillary variant of mucinous breast carcinoma: A distinct subtype, Breast J24 (2018), 339-342.
[9] P. Sun, Z. Zhong, Q. Lu, M. Li, X. Chao, D. Chen, W. Hu, R. Luo and J. He, Mucinous carcinoma with micropapillary features is morphologically, clinically and genetically distinct from pure mucinous carcinoma of breast, Mod Pathol (2020).
[10] Y. Mao, W. Fan, H. Hu, L. Zhang, J. Michel, Y. Wu, J. Wang, L. Jia, X. Tang, L. Xu, Y. Chen, J. Zhu, Z. Feng, L. Xu, R. Yin and Q. Tang, MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells, J Hematol Oncol12 (2019), 106.
[11] Y. Mao, L. Xu, J. Wang, L. Zhang, N. Hou, J. Xu, L. Wang, S. Yang, Y. Chen, L. Xiong, J. Zhu, W. Fan and J. Xu, ROR1 associates unfavorable prognosis and promotes lymphoma growth in DLBCL by affecting PI3K/Akt/mTOR signaling pathway, Biofactors45 (2019), 416-426.
[12] K.Y. Ha, P. Deleon and W. Deleon, Invasive mucinous carcinoma of the breast, Proc (Bayl Univ Med Cent)26 (2013), 295-7.
[13] Y. Asano, S. Kashiwagi, M. Nagamori, S. Tanaka, Y. Kuwae, R. Amano, T. Takashima, M. Ohsawa, K. Hirakawa and M. Ohira, Pure Mucinous Breast Carcinoma with Micropapillary Pattern (MUMPC): A Case Report, Case Rep Oncol12 (2019), 554-559.
[14] S. Di Saverio, J. Gutierrez and E. Avisar, A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma, Breast Cancer Res Treat111 (2008), 541-7.
[15] V. Barbashina, A.D. Corben, M. Akram, C. Vallejo and L.K. Tan, Mucinous micropapillary carcinoma of the breast: an aggressive counterpart to conventional pure mucinous tumors, Hum Pathol44 (2013), 1577-85.
[16] C.R. Barkley, J.A. Ligibel, J.S. Wong, S. Lipsitz, B.L. Smith and M. Golshan, Mucinous breast carcinoma: a large contemporary series, Am J Surg196 (2008), 549-51.
[17] M.F. Mercogliano, G. Inurrigarro, M. De Martino, L. Venturutti, M.A. Rivas, R. Cordo-Russo, C.J. Proietti, E.A. Fernandez, I. Frahm, S. Barchuk, D.H. Allemand, S. Figurelli, E.G. Deza, S. Ares, F.G. Gercovich, E. Cortese, M. Amasino, P. Guzman, J.C. Roa, P.V. Elizalde and R. Schillaci, Invasive micropapillary carcinoma of the breast overexpresses MUC4 and is associated with poor outcome to adjuvant trastuzumab in HER2-positive breast cancer, BMC Cancer17 (2017), 895.
[18] F. Liu, M. Yang, Z. Li, X. Guo, Y. Lin, R. Lang, B. Shen, G. Pringle, X. Zhang and L. Fu, Invasive micropapillary mucinous carcinoma of the breast is associated with poor prognosis, Breast Cancer Res Treat151 (2015), 443-51.
[19] L. Garcia-Labastida, R. Garza-Guajardo, O. Barboza-Quintana, I.P. Rodriguez-Sanchez, J. Ancer-Rodriguez, J.P. Flores-Gutierrez and G.S. Gomez-Macias, CDX-2, MUC-2 and B-catenin as intestinal markers in pure mucinous carcinoma of the breast, Biol Res47 (2014), 43.
[20] S. Matsukita, M. Nomoto, S. Kitajima, S. Tanaka, M. Goto, T. Irimura, Y.S. Kim, E. Sato and S. Yonezawa, Expression of mucins (MUC1, MUC2, MUC5AC and MUC6) in mucinous carcinoma of the breast: comparison with invasive ductal carcinoma, Histopathology42 (2003), 26-36.
[21] E. Varadharajan, S. Priya, G. Prakash, A. Mugundan and P. Easwaramurthi, Mucinous Carcinoma of the Breast with Neuroendocrine Differentiation, Iran J Pathol10 (2015), 231-6.
[22] T. Shet and R. Chinoy, Presence of a micropapillary pattern in mucinous carcinomas of the breast and its impact on the clinical behavior, Breast J14 (2008), 412-20.
[23] H. Gokce, M.G. Durak, M.M. Akin, T. Canda, P. Balci, H. Ellidokuz, B. Demirkan, I.B. Gorken, A.I. Sevinc, M.A. Kocdor, S. Saydam and O. Harmancioglu, Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma, Breast J19 (2013), 374-81.
[24] H. Goncalves, Jr., M.R. Guerra, J.R. Duarte Cintra, V.A. Fayer, I.V. Brum and M.T. Bustamante Teixeira, Survival Study of Triple-Negative and Non-Triple-Negative Breast Cancer in a Brazilian Cohort, Clin Med Insights Oncol12 (2018), 1179554918790563.